Clinical and economic outcomes of oral linezolid versus intravenous vancomycin in the treatment of MRSA-complicated, lower-extremity skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus (Q46429720)
Jump to navigation
Jump to search
scientific article published in April 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Clinical and economic outcomes of oral linezolid versus intravenous vancomycin in the treatment of MRSA-complicated, lower-extremity skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus |
scientific article published in April 2005 |
Statements
1 reference
Clinical and economic outcomes of oral linezolid versus intravenous vancomycin in the treatment of MRSA-complicated, lower-extremity skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus (English)
1 reference
J Neal Sharpe
1 reference
Eugene H Shively
1 reference
Hiram C Polk
1 reference
1 April 2005
1 reference
189
1 reference
4
1 reference
425-428
1 reference
Identifiers
1 reference